Author: Matthew Ferguson

Understanding antimicrobial resistance: from measurement to better decision-making

A resident doctor reviews a patient late in the day. The presence of an infection is uncertain. The guidelines are long and complex, and time is limited. The consultant wants a decision. The patient is expecting treatment.

Does the doctor prescribe antibiotics or not?

This is the reality of antimicrobial prescribing in hospitals. Decisions are often made under pressure, shaped not only by clinical evidence but by time constraints, hierarchy and patient expectations. These decisions matter. Every unnecessary or inappropriate prescription contributes, in small but cumulative ways, to a much larger global challenge: antimicrobial resistance (AMR).

AMR occurs when microbes such as bacteria, viruses, fungi and parasites no longer respond to the drugs used to treat them.

IGHI at Digital Health Rewired 2026: Shaping the future of digital health

The Institute of Global Health Innovation (IGHI) at Imperial College London will showcase its work in digital health, leadership and policy at Digital Health Rewired 2026. The event brings together digital health leaders, innovators and policymakers from across the UK.

Taking place on 24–25 March at the NEC Birmingham, Rewired will bring together experts from across healthcare, technology and research to explore how digital innovation is transforming health systems. Across the two-day programme, IGHI researchers, educators and partners will take part in keynote conversations and panel discussions exploring how data, artificial intelligence and research-led leadership are shaping the future of healthcare.